evoke study semaglutide Live Updates on Semaglutide's Current and Future Uses Evaluating GLP-1 Receptor Agonist Semaglutide

Work with licensed healthcare providers to determine whether a GLP-1 treatment may be appropriate for your health goals

Further funding was sought and from 1st August 2019 an investigator led grant was obtained from Invex therapeutics

Beyond glucose regulation, tirzepatide significantly affects appetite and satiety through central nervous system pathways

Erectile Effects of Other Antidiabetic Therapies: Mechanistic Insights and Clinical Evidence Multiple studies have examined the effects of antidiabetic therapies on erectile function, but findings remain inconsistent and at times contradictory

This complication occurred despite the absence of other medications known to impair gastrointestinal motility, strengthening the temporal association with semaglutide [14]

The broad, shortage-based compounding pathway ended after the FDA resolved the semaglutide and tirzepatide shortages, and in April 2026 the FDA proposed excluding these drugs from the 503B outsourcing-facility bulks list, with a comment period through June 29, 2026